1. Home
  2. METCB vs PHAR Comparison

METCB vs PHAR Comparison

Compare METCB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc. Class B

METCB

Ramaco Resources Inc. Class B

HOLD

Current Price

$11.45

Market Cap

782.1M

Sector

Energy

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.39

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METCB
PHAR
Founded
2015
1988
Country
United States
Netherlands
Employees
900
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.1M
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
METCB
PHAR
Price
$11.45
$13.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$34.00
$38.33
AVG Volume (30 Days)
26.9K
12.3K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
$13.89
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$7.13
$9.54
52 Week High
$22.11
$21.34

Technical Indicators

Market Signals
Indicator
METCB
PHAR
Relative Strength Index (RSI) 61.14 40.26
Support Level $9.72 $12.98
Resistance Level $12.43 $13.44
Average True Range (ATR) 0.63 0.45
MACD 0.21 0.13
Stochastic Oscillator 79.87 65.80

Price Performance

Historical Comparison
METCB
PHAR

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: